124 related articles for article (PubMed ID: 10539850)
1. Coronary artery disease after heart transplantation and its relation to cytomegalovirus.
Hosenpud JD
Am Heart J; 1999 Nov; 138(5 Pt 2):S469-72. PubMed ID: 10539850
[TBL] [Abstract][Full Text] [Related]
2. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology.
Arkonac B; Mauck KA; Chou S; Hosenpud JD
J Heart Lung Transplant; 1997 Oct; 16(10):1035-45. PubMed ID: 9361246
[TBL] [Abstract][Full Text] [Related]
3. Role of cytomegalovirus in cardiac allograft vasculopathy.
Weill D
Transpl Infect Dis; 2001; 3 Suppl 2():44-8. PubMed ID: 11926750
[TBL] [Abstract][Full Text] [Related]
4. Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy.
Srivastava R; Curtis M; Hendrickson S; Burns WH; Hosenpud JD
Transplantation; 1999 Nov; 68(10):1568-73. PubMed ID: 10589956
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection and cardiac allograft vasculopathy.
Koskinen PK; Kallio EA; Tikkanen JM; Sihvola RK; Häyry PJ; Lemström KB
Transpl Infect Dis; 1999 Jun; 1(2):115-26. PubMed ID: 11428979
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells.
Hosenpud JD; Chou SW; Wagner CR
Transplantation; 1991 Nov; 52(5):896-903. PubMed ID: 1658993
[TBL] [Abstract][Full Text] [Related]
7. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.
Lemström K; Koskinen P; Krogerus L; Daemen M; Bruggeman C; Häyry P
Circulation; 1995 Nov; 92(9):2594-604. PubMed ID: 7586362
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
[TBL] [Abstract][Full Text] [Related]
10. Cardiac allograft vasculopathy: a review.
Weis M; von Scheidt W
Circulation; 1997 Sep; 96(6):2069-77. PubMed ID: 9323100
[TBL] [Abstract][Full Text] [Related]
11. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus induces class II expression in rat heart endothelial cells.
Ustinov JA; Loginov RJ; Bruggeman CA; van der Meide PH; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(4):644-51. PubMed ID: 8396436
[TBL] [Abstract][Full Text] [Related]
13. Infectious agents in coronary artery disease: viral infection, aspirin, and gene expression in human coronary smooth muscle cells.
Speir E; Yu ZX; Ferrans VJ
Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II33-9. PubMed ID: 9835780
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
15. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
16. Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection.
Normann SJ; Salomon DR; Leelachaikul P; Khan SR; Staples ED; Alexander JA; Mayfield WR; Knauf DG; Sadler LA; Selman S
J Heart Lung Transplant; 1991; 10(5 Pt 1):674-87. PubMed ID: 1659903
[TBL] [Abstract][Full Text] [Related]
17. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study.
Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ
Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
19. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
[TBL] [Abstract][Full Text] [Related]
20. Impact of immunosuppressive drugs on the development of cardiac allograft vasculopathy.
Dandel M; Hetzer R
Curr Vasc Pharmacol; 2010 Sep; 8(5):706-19. PubMed ID: 20649510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
